Cargando…

A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.

Lysozyme is an ubiquitous enzyme found in most biological secretions and leukocytes. This study was aimed at investigating its interaction with other inflammatory mediators on mucosa surfaces, particularly the complement system. Lysozyme has been shown in our present study, to inhibit the haemolytic...

Descripción completa

Detalles Bibliográficos
Autor principal: Ogundele, M O
Formato: Texto
Lenguaje:English
Publicado: 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781862/
https://www.ncbi.nlm.nih.gov/pubmed/9883972
_version_ 1782131993870336000
author Ogundele, M O
author_facet Ogundele, M O
author_sort Ogundele, M O
collection PubMed
description Lysozyme is an ubiquitous enzyme found in most biological secretions and leukocytes. This study was aimed at investigating its interaction with other inflammatory mediators on mucosa surfaces, particularly the complement system. Lysozyme has been shown in our present study, to inhibit the haemolytic activity of serum complement in a dose-dependent fashion, when tested within the levels present in normal and inflamed breast-milk samples, and other mucosal secretions. This represents a new anti-inflammatory action of lysozyme in relation to the serum complement, and the exact mode of the interaction need further studies.
format Text
id pubmed-1781862
institution National Center for Biotechnology Information
language English
publishDate 1998
record_format MEDLINE/PubMed
spelling pubmed-17818622007-01-25 A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation. Ogundele, M O Mediators Inflamm Research Article Lysozyme is an ubiquitous enzyme found in most biological secretions and leukocytes. This study was aimed at investigating its interaction with other inflammatory mediators on mucosa surfaces, particularly the complement system. Lysozyme has been shown in our present study, to inhibit the haemolytic activity of serum complement in a dose-dependent fashion, when tested within the levels present in normal and inflamed breast-milk samples, and other mucosal secretions. This represents a new anti-inflammatory action of lysozyme in relation to the serum complement, and the exact mode of the interaction need further studies. 1998 /pmc/articles/PMC1781862/ /pubmed/9883972 Text en
spellingShingle Research Article
Ogundele, M O
A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
title A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
title_full A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
title_fullStr A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
title_full_unstemmed A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
title_short A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
title_sort novel anti-inflammatory activity of lysozyme: modulation of serum complement activation.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781862/
https://www.ncbi.nlm.nih.gov/pubmed/9883972
work_keys_str_mv AT ogundelemo anovelantiinflammatoryactivityoflysozymemodulationofserumcomplementactivation
AT ogundelemo novelantiinflammatoryactivityoflysozymemodulationofserumcomplementactivation